About: Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique (publié 2007) (fr) наукова стаття, опублікована в січні 2007 (uk) im Januar 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2007 (ast) artikull shkencor i botuar më 01 janar 2007 (sq) scientific article published on 01 January 2007 (en) գիտական հոդված հրատարակված 2007 թվականի հունվարի 1-ին (hy)
publication date	wds:Q79796272-94791BCA-E413-4339-BA5D-D710228049D8
publication date	2007-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q79796272-B811D85B-7C24-4CC2-8167-13B398587F15
exact match	https://scigraph.springernature.com/pub.10.1007/s00246-006-1390-4
cites work	wds:Q79796272-0CA11970-37C7-4179-812C-3D7E001C9CC3 wds:Q79796272-19DB983A-7587-4751-B86C-CDF07589A521 wds:Q79796272-3126A6C3-F1F4-46C6-9925-07EBA39F168B wds:Q79796272-36D468FE-CD6F-455E-BAE0-3C84B2D3243F wds:Q79796272-371EECB4-C83D-419E-9A7F-DE4A86765DF4 wds:Q79796272-3B9D9B08-8A90-4B82-A6D2-2477D21899BF wds:Q79796272-4B373A7F-54C7-420A-9608-208D17F1B6C2 wds:Q79796272-4BD02F7A-A06A-4641-9C5B-2836FCC6627C wds:Q79796272-4D2F4E64-3788-48DC-97C5-E2DD4F3DA128 wds:Q79796272-5191389A-C3EF-4515-8F39-2F976788BC91 wds:Q79796272-51BB4F00-41A6-44D4-9B29-878A395B26EF wds:Q79796272-5B1FA508-6A4D-4A83-8F1F-27A6499E60D0 wds:Q79796272-6106F198-C8AB-4280-AA15-8F8471DD0246 wds:Q79796272-682DBC26-D091-42B5-AD83-5A7537BF6133 wds:Q79796272-6E963376-DB21-4A3B-83ED-935276929DC6 wds:Q79796272-6F801F06-7831-46EC-8627-A42511B412FF wds:Q79796272-7976D39B-9536-4C71-9AD8-51E339C25C55 wds:Q79796272-7DFAF4EE-D046-477B-892C-EAADC7C7FCEA wds:Q79796272-7F669141-EE12-4155-A227-FDA3298C44AB wds:Q79796272-7F927A83-6693-4523-BCAC-38638D41CE10 wds:Q79796272-86A565B8-5581-4799-9992-F9EBD8013F37 wds:Q79796272-86BFD658-01DF-4CA9-B1A5-9030B28F9189 wds:Q79796272-8880552D-8F1A-4126-8B5F-4CA3ADC550A6 wds:Q79796272-96567C53-CAC0-44D1-980E-FA703FE714DB wds:Q79796272-A0FBFE65-90C5-4F27-A8D8-F2DC5E6D5A34 wds:Q79796272-A77886AF-5EA1-4F2F-8211-57245B9A573A wds:Q79796272-A91974AE-B954-4D96-B21C-E8C220772059 wds:Q79796272-B2FA47C3-C013-4CC1-8D4C-1E5BCE0E5AE2 wds:Q79796272-BFFBFCB4-4EE0-4B7C-84C2-F0B8174A0029 wds:Q79796272-CB4325AA-1949-42AD-A51B-22B0606C0D8E wds:Q79796272-CB54C02C-C6A2-4F9A-AAB5-9F85652E032B wds:Q79796272-DA0CA002-EC37-4947-BFA4-1CF06B56A72D wds:Q79796272-DF85B15E-38E7-4C9B-9C64-183F924DCF6F wds:Q79796272-E39F6B41-680F-4805-9A9F-5FB97E9F282D wds:Q79796272-E4F2BEF4-8DB3-4232-8824-529BC1D807AC wds:Q79796272-E91AC8D6-AB73-49FC-B22B-C1FA937D5818 wds:Q79796272-F5374CCC-62B1-4DC3-9E84-404C17CABAF1
cites work	Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis Centers for Disease Control and Prevention 2000 Growth Charts for the United States: Improvements to the 1977 National Center for Health Statistics Version Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents Impact of high-normal blood pressure on the risk of cardiovascular disease Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Single-void urine samples can be used to estimate quantitative microalbuminuria. Vascular inflammation: a role in vascular disease in hypertension? Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine Feasibility of treating prehypertension with an angiotensin-receptor blocker Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging Microalbuminuria and endothelial dysfunction in essential hypertension Quantitation of microalbuminuria using random urine samples Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction Renoprotection: one or many therapies? Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease Glomerular hyperfiltration in hypertensive African Americans Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications High-normal blood pressure and microalbuminuria Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Surface area estimation: pocket calculator v nomogram Microalbuminuria as a marker of preclinical diastolic dysfunction in never-treated essential hypertensives. IgA nephropathy and inhibitors of the renin angiotensin system: is reduction in proteinuria adequate proof of efficacy?
rdfs:label	Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (en) Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (nl) Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (sq)
skos:prefLabel	Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (en) Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (nl) Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (sq)
name	Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (en) Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (nl) Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (sq)
author	wds:Q79796272-9AAE76D7-1868-433B-B101-EFC17DAC7478
author	Farahnak Assadi
title	wds:Q79796272-5BAC8E9B-9AB4-4518-9F05-56810D0776DA
title	Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software